VivoSense® is a sophisticated software platform designed to analyze and interpret data from wearable sensors, providing real-world digital clinical measures for healthcare research, clinical trials, and patient wellness. By leveraging data from body-worn devices, VivoSense® enables the development of novel digital biomarkers, facilitating patient-focused drug development and precision medicine across various therapeutic areas, including oncology, neurodegenerative diseases, and rare conditions. Key Features and Functionality: - Comprehensive Data Analysis: VivoSense® offers advanced tools for the visualization and analysis of physiological data collected from wearable sensors, ensuring accurate interpretation of complex biological signals. - Integration with Wearable Devices: The platform is compatible with various wearable technologies, such as the Hexoskin smart shirt, allowing seamless data import and synchronization for comprehensive health monitoring. - Development of Digital Biomarkers: VivoSense® facilitates the creation and validation of digital biomarkers, which serve as primary and secondary clinical endpoints in regulated pharmaceutical trials. - Regulatory Compliance: The software adheres to regulatory standards, providing analytical and clinical validation necessary for FDA approval and ensuring the reliability of digital clinical outcome assessments. Primary Value and Problem Solved: VivoSense® addresses the challenge of accurately measuring drug and treatment effects in patients by harnessing data from wearable sensors. Traditional clinical assessments often rely on infrequent, in-clinic evaluations, which may not capture the full spectrum of a patient's physiological responses. By enabling continuous, real-world monitoring, VivoSense® provides a more comprehensive and objective assessment of patient health, enhancing the quality and efficiency of clinical trials and healthcare research. This approach reduces the burden on patients and clinicians, standardizes the measurement of complex physiological parameters, and accelerates the development of life-saving treatments.